中东和非洲自我监测血糖设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按组件(血糖仪设备、试纸和柳叶刀)和地理划分。

市场快照

Middle-East and Africa self-monitoring blood glucose devices market Overview
Study Period: 2016-2027
Base Year: 2021
CAGR: >7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,中东和非洲的自我监测血糖设备市场有望以超过 7% 的复合年增长率增长。由于糟糕的生活方式选择,中东和非洲的糖尿病人口增加,直接导致自我监测血糖设备 (SMBG) 市场出现可观的增长。不断增长的 1 型人口也有助于市场的增长。建议 1 型糖尿病患者每天至少检测 3 次血糖,这有助于患者计划胰岛素给药。此外,这些设备有助于早期检测低血糖和高血糖状况,这往往会推动血糖监测市场。血糖仪在几秒钟内显示结果并记录数据。

报告范围

该报告包括一项关于自我监测血糖的完整研究,其中包括血糖仪设备、血糖试纸和柳叶刀。该报告提供了最新的趋势、规模、份额和行业概况。

Self-monitoring Blood Glucose Devices
By Component (Value and Volume, 2016 - 2026)
Glucometer Devices
Test Strips
Lancets
By Geography
Middle-East and Africa
Egypt (Value and Volume, 2016 - 2026)
By Component (Glucometer Device, Test Strips, and Lancets)
Iran (Value and Volume, 2016 - 2026)
By Component (Glucometer Device, Test Strips, and Lancets)
Saudi Arabia (Value and Volume, 2016 - 2026)
By Component (Glucometer Device, Test Strips, and Lancets)
Oman (Value and Volume, 2016 - 2026)
By Component (Glucometer Device, Test Strips, and Lancets)
South Africa (Value and Volume,2016 - 2026)
By Component (Glucometer Device, Test Strips, and Lancets)
Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)
By Component (Glucometer Device, Test Strips, and Lancets)

Report scope can be customized per your requirements. Click here.

主要市场趋势

2020年试纸市场占有率最高

在中东和非洲的自测血糖仪市场,试纸以2020年1亿的收入占据最高份额。价格往往是购买血糖试纸的一个重要问题。尽管各个国家都为处方试纸提供报销,但大多数患者必须自掏腰包支付费用。监测血糖水平的频率取决于糖尿病的类型,并且因患者而异。1型糖尿病患者需要定期检查血糖水平,以相应调整胰岛素剂量。因此,如果患者一天进行 5-6 次检测,试纸的平均支出将超过 180 美元/月。这些费用增加了已经很高的糖尿病管理成本,并阻碍了市场增长。

Middle-East and Africa Self-monitoring Blood Glucose Market_test strip

2020年沙特阿拉伯在中东和非洲自测血糖市场占有率超过43%

中东和非洲自我监测血糖市场的主要市场是沙特阿拉伯,占 43% 的市场份额,其次是伊朗和其他国家。这些设备在沙特阿拉伯的高销量是由于该国糖尿病患病率不断上升。2020 年,沙特阿拉伯有 540 万糖尿病患者。沙特阿拉伯科学糖尿病协会最近的一项调查表明,超过 52% 的 2 型糖尿病患者死于心血管并发症,这使沙特阿拉伯成为该地区糖尿病和肥胖症药物的主要市场。

Middle-East and Africa Self-Monitoring Blood Glucose Market_country

竞争格局

自我监测血糖设备市场分散,少数主要制造商吹嘘其全球市场份额,而其余制造商则仅限于其他本地区域。近期参与者之间发生的并购有助于这些公司加强其市场占有率。例如,Ascensia Diabetes Care 和 Glooko 建立了合作伙伴关系,将 Ascensia 血糖仪的数据同步到 Glooko 的多功能监测平台。中东和北非的 ALRT 糖尿病解决方案在患者和糖尿病医疗团队之间提供了一个负担得起且易于使用的通信网络。医疗保健提供者可以及时获取患者自己上传的患者血糖信息。

RECENT DEVELOPMENTS

In 2020, The Riyadh Declaration on Digital Health was launched during the Riyadh Global Digital Health Summit, a forum that championed the value of digital technology, data, and innovation for overall population health and healthcare systems. The key priorities are adopting health intelligence, interoperable digital technology, artificial intelligence (AI), effective communication, data governance, data quality, and innovation in the healthcare sector.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Self-monitoring Blood Glucose Devices

      1. 5.1.1 By Component (Value and Volume, 2016 - 2026)

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

    2. 5.2 By Geography

      1. 5.2.1 Middle-East and Africa

        1. 5.2.1.1 Egypt (Value and Volume, 2016 - 2026)

          1. 5.2.1.1.1 By Component (Glucometer Device, Test Strips, and Lancets)

        2. 5.2.1.2 Iran (Value and Volume, 2016 - 2026)

          1. 5.2.1.2.1 By Component (Glucometer Device, Test Strips, and Lancets)

        3. 5.2.1.3 Saudi Arabia (Value and Volume, 2016 - 2026)

          1. 5.2.1.3.1 By Component (Glucometer Device, Test Strips, and Lancets)

        4. 5.2.1.4 Oman (Value and Volume, 2016 - 2026)

          1. 5.2.1.4.1 By Component (Glucometer Device, Test Strips, and Lancets)

        5. 5.2.1.5 South Africa (Value and Volume,2016 - 2026)

          1. 5.2.1.5.1 By Component (Glucometer Device, Test Strips, and Lancets)

        6. 5.2.1.6 Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)

          1. 5.2.1.6.1 By Component (Glucometer Device, Test Strips, and Lancets)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2016 - 2026)

    2. 6.2 Type-2 Diabetes population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Abbott

      2. 7.1.2 F. Hoffmann-La Roche AG

      3. 7.1.3 Platinum Equity (lifeScan)

      4. 7.1.4 Arkray

      5. 7.1.5 Ascensia

      6. 7.1.6 Agamatrix Inc.

      7. 7.1.7 Medisana

      8. 7.1.8 Trivida

      9. 7.1.9 I-SENS

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Middle-East and Africa Self-monitoring Blood Glucose Devices Market market is studied from 2016 - 2027.

The Middle-East and Africa Self-monitoring Blood Glucose Devices Market is growing at a CAGR of >7% over the next 5 years.

The Middle-East and Africa Self-monitoring Blood Glucose Devices Market is valued at 191 Million USD in 2016.

The Middle-East and Africa Self-monitoring Blood Glucose Devices Market is valued at 289 Million USD in 2027.

Abbott, Ascensia, Platinum Equity (LifeScan), F. Hoffmann-La Roche AG, Ascensia are the major companies operating in Middle-East and Africa Self-monitoring Blood Glucose Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!